@inproceedings{inproceedings, title  = {{Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{http://dx.doi.org/10.1200/jco.2008.26.15_suppl.8009 }},

 year = {{2008}},

 month = {{5}},

 author = {{Heymach JV and Hanrahan EO and Mann H and Langmuir P and Natale RB and Johnson BE and Herbst RS and Ryan AJ}},

 doi = {{10.1200/jco.2008.26.15_suppl.8009}},

 volume = {{26}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{8009-8009}},

 note = {{Accessed on 2024/12/22}}}